Literature DB >> 22206954

High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure.

Maseeha S Khaleel1, Tracy A Dorheim, Michael J Duryee, Harold E Durbin, Walter D Bussey, Robert P Garvin, Lynell W Klassen, Geoffrey M Thiele, Daniel R Anderson.   

Abstract

BACKGROUND: Coronary artery disease is the single leading cause of death in the United States. Commonly it is treated with coronary bypass grafting using the saphenous vein (SV) or internal mammary artery (IMA) as a conduit. Unfortunately, the SV has much lower patency rates compared with the IMA. Several hypotheses exist as to why occlusion occurs more commonly in SV grafts than in IMA grafts. However detailed studies in this area have been limited. This study investigates the effects of pressure distention on inflammation in SV conduit used in coronary artery bypass grafting (CABG).
METHODS: Saphenous vein distention pressure was measured intraoperatively during 48 CABG procedures. A segment of SV was excised from the conduit before distention. Because the vein was used for coronary artery grafting, sequential pieces were archived for evaluation. Real-time polymerase chain reaction (RT-PCR) and immunohistochemical analyses were performed to investigate a change in the expression of biomarkers.
RESULTS: Upregulation of various biomarkers occurred. These biomarkers included scavenger receptors A and B (SR-A, SR-B), toll-like receptors 2 and 4 (TLR2, TLR4), platelet endothelial cell adhesion molecule (PECAM), vascular cell adhesion molecule (VCAM), and intercellular cell adhesion molecule (ICAM) in segments of SV that were subjected to distention. Immunohistochemical results mirrored RT-PCR findings. A significant correlation was observed between biomarkers and pressure values.
CONCLUSIONS: These studies demonstrate that markers of inflammation are upregulated in response to SV distention. The data suggest that the pressure used in graft preparation procedures should be regulated to avoid inflammation and its potential to induce graft failure.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22206954     DOI: 10.1016/j.athoracsur.2011.10.035

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  23 in total

1.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

2.  Pressure control during preparation of saphenous veins.

Authors:  Fan Dong Li; Susan Eagle; Colleen Brophy; Kyle M Hocking; Michael Osgood; Padmini Komalavilas; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

3.  Does No-Touch Technique Better than Conventional or Intermediate Saphenous Vein Harvest Techniques for Coronary Artery Bypass Graft Surgery: a Systematic Review and Meta-analysis.

Authors:  Abdelrahman Elshafay; Ahmed Hesham Bendary; Huan Thanh Vuong; Ahmed Reda Ahmed; Mohamed Ashraf Mokhtar; Ali Lotfy Soliman; Nguyen Lam Vuong; Israa Atia El Bestawi; Nirmeen Atef Abdallah; Vi Tuong Vu; Kenji Hirayama; Nguyen Tien Huy
Journal:  J Cardiovasc Transl Res       Date:  2018-10-12       Impact factor: 4.132

4.  Short-term preoperative protein restriction attenuates vein graft disease via induction of cystathionine γ-lyase.

Authors:  Kaspar M Trocha; Peter Kip; Ming Tao; Michael R MacArthur; J Humberto Treviño-Villarreal; Alban Longchamp; Wendy Toussaint; Bart N Lambrecht; Margreet R de Vries; Paul H A Quax; James R Mitchell; C Keith Ozaki
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

Review 5.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

6.  Impact of the size mismatch between saphenous vein graft and coronary artery on graft patency.

Authors:  Yoshitaka Yamane; Naomichi Uchida; Shuhei Okubo; Hironobu Morimoto; Shogo Mukai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-08-02

7.  Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium.

Authors:  Takuya Hashimoto; Kota Yamamoto; Trenton Foster; Hualong Bai; Kunihiro Shigematsu; Alan Dardik
Journal:  J Vis Exp       Date:  2016-03-04       Impact factor: 1.355

Review 8.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

9.  Inside-out autologous vein grafts fail to restore erectile function in a rat model of cavernous nerve crush injury after nerve-sparing prostatectomy.

Authors:  T Bessede; D Moszkowicz; B Alsaid; M Zaitouna; D Diallo; F Peschaud; G Benoit; S Droupy
Journal:  Int J Impot Res       Date:  2014-07-31       Impact factor: 2.896

10.  Traditional graft preparation decreases physiologic responses, diminishes viscoelasticity, and reduces cellular viability of the conduit: A porcine saphenous vein model.

Authors:  Eric S Wise; Kyle M Hocking; Weifeng Luo; Daniel L Feldman; Jun Song; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Vasc Med       Date:  2016-05-23       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.